ID   MER
AC   CVCL_A5YL
SY   mer
DR   Wikidata; Q107116345
RX   DOI=10.1007/0-306-46877-8_4;
RX   PubMed=8051085;
RX   PubMed=8427968;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 5
//
RX   DOI=10.1007/0-306-46877-8_4;
RA   Jernberg-Wiklund H., Nilsson K.;
RT   "Multiple myeloma cell lines.";
RL   (In book chapter) Human cell culture. Vol. 3. Cancer cell lines part 3; Masters J.R.W., Palsson B.O. (eds.); pp.81-155; Kluwer Academic Publishers; New York; USA (2000).
//
RX   PubMed=8051085; DOI=10.1016/S0021-9258(17)32120-8;
RA   Liebersbach B.F., Sanderson R.D.;
RT   "Expression of syndecan-1 inhibits cell invasion into type I
RT   collagen.";
RL   J. Biol. Chem. 269:20013-20019(1994).
//
RX   PubMed=8427968; DOI=10.1182/blood.V81.3.767.767;
RA   Ridley R.C., Xiao H.-Q., Hata H., Woodliff J., Epstein J.,
RA   Sanderson R.D.;
RT   "Expression of syndecan regulates human myeloma plasma cell adhesion
RT   to type I collagen.";
RL   Blood 81:767-774(1993).
//